Total Payments
$40,612
2024 Payments
$2,270
Companies
46
Transactions
161
Medicare Patients
3,025
Medicare Billing
$391,613
Payment Breakdown by Category
Other$26,750 (65.9%)
Travel$7,398 (18.2%)
Food & Beverage$3,759 (9.3%)
Consulting$2,615 (6.4%)
Education$89.87 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,750 | 10 | 65.9% |
| Travel and Lodging | $7,398 | 12 | 18.2% |
| Food and Beverage | $3,759 | 135 | 9.3% |
| Consulting Fee | $2,615 | 2 | 6.4% |
| Education | $89.87 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $32,892 | 33 | $0 (2018) |
| Clovis Oncology, Inc. | $3,296 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,999 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $283.57 | 14 | $0 (2024) |
| Genentech USA, Inc. | $226.15 | 10 | $0 (2024) |
| Intuitive Surgical, Inc. | $177.75 | 4 | $0 (2021) |
| Neomend, Inc. | $166.52 | 2 | $0 (2017) |
| Eisai Inc. | $146.08 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $133.27 | 2 | $0 (2022) |
| Amgen Inc. | $111.43 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,270 | 21 | AstraZeneca Pharmaceuticals LP ($1,773) |
| 2023 | $120.96 | 6 | Merck Sharp & Dohme LLC ($41.57) |
| 2022 | $328.18 | 16 | Merck Sharp & Dohme LLC ($89.21) |
| 2021 | $73.02 | 2 | Intuitive Surgical, Inc. ($73.02) |
| 2020 | $192.97 | 9 | CONMED Corporation ($57.05) |
| 2019 | $557.17 | 31 | Intuitive Surgical, Inc. ($81.73) |
| 2018 | $22,211 | 43 | TESARO, Inc. ($18,735) |
| 2017 | $14,858 | 33 | TESARO, Inc. ($14,156) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Genentech USA, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: BioOncology | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: DESMOID TUMORS | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Oncology | ||||||
| 06/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Oncology | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,715.00 | General |
| Category: Oncology | ||||||
| 05/09/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/02/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Oncology | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $122.10 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $42.42 | General |
| Category: Hemodynamic Monitoring | ||||||
| 03/22/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Oncology | ||||||
| 02/15/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $26.05 | General |
| 02/01/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NONE | ||||||
| 01/27/2024 | Ethicon US, LLC | ETHICON (Device), VISTASEAL, DERMABOND PRINEO | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Biosurgical | ||||||
| 01/26/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Oncology | ||||||
| 01/04/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $13.24 | General |
| 11/11/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Oncology | ||||||
| 11/03/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Oncology | ||||||
| 10/05/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 102 | 261 | $53,296 | $14,669 |
| 2022 | 26 | 847 | 25,037 | $433,810 | $112,542 |
| 2021 | 32 | 1,063 | 4,895 | $311,941 | $134,512 |
| 2020 | 29 | 1,013 | 12,807 | $313,448 | $129,890 |
Total Patients
3,025
Total Services
43,000
Medicare Billing
$391,613
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 45 | $16,560 | $4,643 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 32 | $15,872 | $4,450 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 32 | $8,000 | $2,334 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $9,040 | $2,155 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 67 | $1,340 | $562.80 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 14 | 69 | $2,484 | $525.09 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 214 | $45,955 | $19,594 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 317 | $47,320 | $19,365 | 40.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 32 | 167 | $89,096 | $15,612 | 17.5% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 23 | 23 | $47,727 | $15,132 | 31.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $12,476 | $5,237 | 42.0% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 11 | 32 | $5,120 | $5,110 | 99.8% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 20 | 90 | $22,404 | $4,124 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 25 | $7,913 | $3,364 | 42.5% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2022 | 55 | 123 | $4,428 | $2,548 | 57.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 18 | 109 | $11,879 | $2,168 | 18.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 15 | $5,305 | $2,129 | 40.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 55 | 275 | $4,329 | $2,118 | 48.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 16 | 97 | $13,524 | $2,015 | 14.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 37 | $4,879 | $1,975 | 40.5% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2022 | 16 | 19,642 | $42,934 | $1,887 | 4.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 47 | 170 | $3,060 | $1,777 | 58.1% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2022 | 17 | 764 | $23,728 | $1,665 | 7.0% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 12 | 12 | $3,070 | $1,562 | 50.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 24 | 143 | $12,025 | $1,523 | 12.7% |
About Dr. Alpa Nick, MD
Dr. Alpa Nick, MD is a Gynecologic Oncology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265589139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alpa Nick, MD has received a total of $40,612 in payments from pharmaceutical and medical device companies, with $2,270 received in 2024. These payments were reported across 161 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($26,750).
As a Medicare-enrolled provider, Nick has provided services to 3,025 Medicare beneficiaries, totaling 43,000 services with total Medicare billing of $391,613. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Houston, TX
- Active Since 01/04/2007
- Last Updated 01/23/2024
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1265589139
Products in Payments
- ZEJULA (Drug) $32,892
- Rubraca (Drug) $3,272
- LYNPARZA (Drug) $1,915
- KEYTRUDA (Biological) $268.73
- Da Vinci Surgical System (Device) $177.75
- DAV-Arista AH (Device) $166.52
- Lenvima (Drug) $146.08
- OPDIVO (Biological) $133.27
- Avastin (Biological) $84.83
- IMBRUVICA (Drug) $71.01
- Tivdak (Drug) $60.93
- CONMED SMOKE EVACUATION (Device) $57.05
- Neulasta (Biological) $44.12
- JAKAFI (Drug) $43.13
- HemoSphere (Device) $42.42
- LIBTAYO (Biological) $39.69
- Aranesp (Biological) $39.47
- Balversa (Drug) $35.74
- TAGRISSO (Drug) $35.03
- NERLYNX (Drug) $33.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Houston
Robert Coleman, M.d, M.D
Gynecologic Oncology — Payments: $839,472
Gynecologic Oncology $839,472
Maurie Markman, M.d, M.D
Gynecologic Oncology — Payments: $479,163
Gynecologic Oncology $479,163
Dr. Aparna Kamat, M.d, M.D
Gynecologic Oncology — Payments: $234,318
Gynecologic Oncology $234,318
Anil Sood, M.d, M.D
Gynecologic Oncology — Payments: $70,682
Gynecologic Oncology $70,682
Gordon Mills, Md, Phd, MD, PHD
Gynecologic Oncology — Payments: $41,586
Gynecologic Oncology $41,586
Pamela Soliman, M.d, M.D
Gynecologic Oncology — Payments: $34,839
Gynecologic Oncology $34,839